Efficacy, Safety, Tolerability, Immunogenicity and Pharmacokinetic Evaluation of HYQVIA in Pediatric PIDD Subjects
Clinical trial NCT03277313 · COMPLETED
Trial details
- NCT number
- NCT03277313
- Sponsor
- Baxalta now part of Shire
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-25
- Primary completion
- 2022-07-20
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.